Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 9, 1996, Pages 687-692

  Xu, Xiping ^a,b   Kelsey, Karl T ^a   Wiencke, John K ^c   Wain, John C ^d   Christiani, David C ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

AGED; ASBESTOS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTINENTAL POPULATION GROUPS; CYTOCHROME P-450 CYP1A1; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE AMPLIFICATION; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; JAPAN; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEX FACTORS; SMOKING; SMOKING CESSATION;

EID: 0029835148     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Doll, R., and Hill, A. B. Mortality in relation to smoking: 20 years' observations on male British doctors. Br. Med. J., 2: 1525-1536, 1976.
2. Doll, R. Mortality from lung cancer in asbestos workers. Br. J. Ind. Med., 12: 81-86, 1955.
3. Coultas, D. B., and Samet, J. M. Occupational lung cancer. Clin. Chest Med., 13: 341-354, 1992.
4. Tokuhata, G. K., and Lilienfeld, A. M. Familiar aggregation of lung cancer in humans. J. Natl. Cancer Inst., 30: 289-312, 1963.
5. Ooi, W. L., Elston, R. C., Chen, V. W., Bailey-Wilson, J. E., and Rothschild, H. Increased familial risk for lung cancer. J. Natl. Cancer Inst., 76: 217-222, 1986.
6. Sellers, T. A., Bailey-Wilson, J. E., Elston, R. C., Wilson, A. F., Elston, G. Z., Dot, W. L., and Rothschild, H. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J. Natl. Cancer Inst., 82: 1272-1279, 1990.
7. Ketter, B. Protective role of glutathione and glutathione transferase in mutagenesis and carcinogenesis. Mutat. Res., 202: 343-361, 1988.
8. Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. J. A tobacco-smoke derived nitrosoamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic cytochrome P4502D6. Carcinogenesis (Lond.), 12: 1197-1201, 1991.
9. Kellerman, G., Shaw, C. R., and Luyten-Kellerman, M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 289: 934-937, 1974.
10. Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., Toniolo, P., and Garte, S. J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis (Lond.), 15: 2961-2963, 1994.
11. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. Human dioxin-inducible cytochrome P1450: complimentary DNA amino acid sequence. Science (Washington, DC), 228: 80-83, 1985.
12. Hildebrand, C. E., Gonzalez, F. J., McBride, O. W., and Nebert D. W. Assignment of the human 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible P450 gene to chromosome 15. Nucleic Acids Res., 13: 2009-2016, 1985.
13. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., and Watanabe, J. Identification of genetically high-risk individuals to lung cancer by DNA polymorphism of the cytochrome P450 CYP1A1 gene. FEBS Lett., 236: 131-133, 1990.
14. Hayashi, S. I., Watanabe, J., and Nakachi, K. Genetic linkage of lung cancer associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J. Biochem., 110: 407-411, 1991.
15. Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S., and Vainio, H. Point-mutational MspI and Ile-Val polymorphism closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol., Biomarkers & Prev., 1: 485-489, 1992.
16. 1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1: 20-25, 1991.
17. Alexandrie, A. K., Ingelman-Sundberg, M., Seidegaard, J., Tornling, G., and Rannug, A. Genetic susceptibility to lung cancer: a study of host factors in relation to age of onset and histological cancer types. Carcinogenesis (Lond.), 15: 1785-1790, 1994.
18. Sugimura, H., Suzuki, I., Hamada, G. S., Iwase, T., Takahashi, T., Nagura, K., Iwata, H., Watanabe, S., Kino, I., and Tsugane, S. Cytochrome P-450 IA1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol., Biomarkers & Prev., 3: 145-148, 1994.
19. Shields, P. G., Caporaso, N. E., Falk, R. T., Sugimura, H., Trivers, G., Trump, B. F., Hoover, R. N., Weston, A., and Harris, C. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol., Biomarkers & Prev., 2: 481-485, 1993.
20. Ichiba, M., Hagmar, L., Rannug, A., Hogstedt, B., Alexandrie, A. K., Carstensen, U., and Hemminki, K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTI in chimney sweeps. Carcinogenesis (Lond.), 15: 1347-1352, 1994.
21. Anttila, S., Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Nurminen, T., and Vainio, H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis (Lond.), 15: 1133-1135, 1994.
22. Shields, P. G., Bowman, E. D., Harrington, A. M., Doan, V. T., and Weston, A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53: 3486-3492, 1993.
23. Ferris, B. G. Epidemiology standardized project. Am. Rev. Respir. Dis., 118(Suppl.): 1-120, 1978.
24. Walsh, P. S., Metzger, D. A., and Higuchi, R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques, 10: 506-513, 1991.
25. Hastie, T. J., and Tibshirani, R. J. Generalized Additive Models. New York: Chapman and Hall, Inc., 1990.
26. Okada, T., Kawashima, K., Fukushi, S., Minakuchi, T., and Nishimura, S. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics, 4: 333-340, 1994.
27. Nakachi, K., Imai, K., Hayashi, S-I., Watanabe, J., and Kawajiri, K. Genetic susceptibility to squamous-cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51: 5177-5180, 1991.
28. Taioli, E., Crofts, F., Trachman, J., Demopoulos, R., Toniolo, P., and Garte, S. A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55: 472-473, 1995.
29. Sugimura, H., Suzuki, I., Hamada, G. S., Iwase, T., Takashi, T., Nagura, K., Iwata, H., Watanabe, S., Kino, I., and Tsugane, S. Cytochrome P450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol.. Biomarkers & Prev., 3: 145-148, 1994.